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Background: The use of molecular techniques to detect malaria parasites has been advocated to improve the
accuracy of parasite prevalence estimates, especially in moderate to low endemic settings. Molecular work is
time-consuming and costly, thus the effective gains of this technique need to be carefully evaluated. Light
microscopy (LM) and rapid diagnostic tests (RDT) are commonly used to detect malaria infection in resource
constrained areas, but their limited sensitivity results in underestimation of the proportion of people infected with
Plasmodium falciparum. This study aimed to evaluate the extent of missed infections via a community survey in
Tanzania, using polymerase chain reaction (PCR) to detect P. falciparum parasites and gametocytes.
Methods: Three hundred and thirty individuals of all ages from the Kilombero and Ulanga districts (Tanzania) were
enrolled in a cross-sectional survey. Finger prick blood samples were collected for parasite detection by RDT, LM
and molecular diagnosis using quantitative 18S rRNA PCR and msp2 nPCR. Gametocytes were detected by LM and
by amplifying transcripts of the gametocyte-specific marker pfs25.
Results: Results from all three diagnostic methods were available for a subset of 226 individuals. Prevalence of
P. falciparum was 38% (86/226; 95% CI 31.9–44.4%) by qPCR, 15.9% (36/226; 95% CI 11.1–20.7%) by RDT and 5.8%
(13/226; 95% CI 2.69- 8.81%) by LM. qPCR was positive for 72% (26/36) of the RDT-positive samples. Gametocyte
prevalence was 10.6% (24/226) by pfs25-qRT-PCR and 1.2% by LM.
Conclusions: LM showed the poorest performance, detecting only 15% of P. falciparum parasite carriers identified
by PCR. Thus, LM is not a sufficiently accurate technique from which to inform policies and malaria control or
elimination efforts. The diagnostic performance of RDT was superior to that of LM. However, it is also insufficient
when precise prevalence data are needed for monitoring intervention success or for determining point prevalence
rates in countrywide surveillance. Detection of gametocytes by PCR was 10-times more sensitive than by LM. These
findings support the need for molecular techniques to accurately estimate the human infectious reservoir and
hence the transmission potential in a population.
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Records of Tanzanian malaria indicator surveys show
a general decline in malaria prevalence among chil-
dren under five years of age, from 18% in 2008 to 9%
in 2012 [1,2]. This decline has been attributed to country-
wide implementation of malaria interventions, includ-
ing indoor residual spraying (IRS), mass distribution of
insecticide-treated nets (ITNs), long-lasting ITNs and
the use of artemisinin-based combination therapy (ACT),
which effectively kills both asexual blood stage para-
sites and immature gametocytes, thereby reducing trans-
mission [3,4].
Early diagnosis and prompt treatment are essential for
appropriate malaria management. The World Health
Organization (WHO) recommends laboratory confirm-
ation of malaria before treatment, either by microscopy
or by immuno-chromatographic rapid diagnostic test
(RDT) [5]. Accurate malaria diagnosis is not only im-
portant for case management but also for estimating
parasite prevalence in community surveys. Light micros-
copy (LM) is a standard tool for malaria diagnosis in
resource constrained areas such as Tanzania. However,
its performance is limited due to a lack of expertise and
its low limit of detection (LOD) of about 50 parasites/μL
of blood, which does not allow detection of low parasite
densities [6,7]. Although expert microscopists can attain
a LOD of around 20 parasites/μL of blood [8], such high
sensitivity is hardly ever achieved in field settings. RDTs
are easier to use and their sensitivity is comparable to
that of LM in the field [9,10]. Currently, RDTs are widely
used in community surveys but, owing to a low LOD,
their performance in low endemic field settings is lim-
ited [11].
Recently, molecular tools for parasite detection have
been introduced in many laboratories in endemic
countries and are increasingly applied in monitoring
interventions and epidemiological field surveys [12-14].
These molecular assays have LODs between 0.34–0.002
parasites/μL of blood, which results in more sensitive
and reliable parasite detection. Due to their higher
sensitivity, PCR-based techniques can be used to as-
sess the extent to which parasite prevalence has been
underestimated in endemic settings such as Tanzania,
where malaria prevalence is routinely measured by clas-
sical LM [1,15-17], complemented in recent years by
RDTs [2]. So far, only a few studies in Tanzania have
applied molecular techniques for blood stage parasite
detection and even fewer for gametocyte detection
[18-21]. Therefore, this study aimed to compare P.
falciparum parasite and sexual stage prevalence rates
as determined by LM and RDT with those obtained
using molecular techniques, thereby assessing the useful-
ness of these different methods for epidemiological studies
in Tanzania.Methods
Study site and design
The study was conducted in the Kilombero and Ulanga
(K-U) districts in Morogoro region in south-east Tanzania.
The Ifakara Demographic Surveillance System (IHDSS)
covers the study area [22]. The districts are primarily
rural. Transmission of malaria is perennial with two rainy
periods: from October to December and from March to
May. The K-U districts were among the first areas in
Tanzania to implement several malaria intervention strat-
egies. The Kilombero Net project (KINET) successfully
distributed ITNs, attaining 91% coverage by late 2000
[23]. This programme led to a four-fold reduction in ento-
mological inoculation rates (EIR) [24] to about 78 infec-
tious bites per year [25].
This study was conducted as an extension of the
artemether-lumefantrine in vulnerable patients: explor-
ing health impacts (ALIVE) project. Its main aim was to
assess the impact of introducing ACT as a first-line anti-
malarial treatment on all-cause mortality in infants/chil-
dren under five years in the K-U districts.
A cross-sectional survey was performed between May
and August 2011. Randomly selected households within
the IHDSS were surveyed. A subset of 330 randomly
selected individuals of all ages was included in the mo-
lecular analysis. The study was granted ethical clearance
by the Ifakara Health Institute (IHI) reference number:
IHI/IRB/AMM/10-2011 and by the National Institute
for Medical Research Tanzania reference number: NIMR/
HQ/R8c/Vol. I/184.
Blood collection and sample storage
Finger prick blood was used to diagnose malaria positivity
by (i) RDT SD Bioline Pan-pLDH/Pf-HRP2, (ii) blood
smear and LM and (iii) PCR-based molecular diagnosis.
Approximately 50 μL of whole blood were collected on
Whatman® grade-3 filter paper, air dried in the field and
stored at ambient temperature in separate sealed plastic
bags with desiccant. Two blood spots on filter paper were
prepared per individual, one of which was put in 300 μL
TRIzol® (Invitrogen) to stabilize RNA and stored at -80°C.
Samples in TRIzol® were shipped by air on refrigerant gel
packs to the laboratory responsible for DNA and RNA
extraction. RNA was extracted from 330 samples using
the Qiagen RNeasy Plus ® protocol with on-column DNase
digestion, to ensure removal of genomic DNA (gDNA) as
described elsewhere [14]. RNA was stored at -20°C for a
maximum of two weeks prior to cDNA synthesis and
amplification. One additional blood spot per patient was
air-dried and preserved in a sealed plastic bag with desic-
cant at -20°C until shipped at room temperature. DNA
was extracted from 226 dried blood spots using the
Chelex protocol [26]. DNA was stored at -20°C for one to
two weeks until used in PCR.
Table 1 Comparison of the two molecular methods Pf18S
rRNA qPCR and msp2 nested PCR for P. falciparum
parasite detection
msp2
18S rRNA qPCR Positive Negative Total
Positive 50 36 86
Negative 10 130 140
Total 60 166 226
Pearson chi2 (1) = 71.0492 Pr = 0.000.
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Thick and thin blood films were prepared in the field,
air dried, Giemsa-stained and read for detection and
quantification of malaria parasites according to Standard
Operating Procedures at the IHI laboratory. Asexual
parasites were reported out of 200 leukocytes. Gameto-
cyte detection by LM was based on a volume of blood
corresponding to 500 leucocytes. Assuming 8,000 leuco-
cytes/μL blood, parasite density (expressed as parasites
per μL blood) was calculated by multiplying LM counts
by a factor of 40 if parasites were reported out of 200
leukocytes or by 16 for 500 leukocytes. Two independent
qualified technicians read all slides. In case of discrepancy
between two readers, a third reader was requested. The
final result was the mean of the two closest readings out
of three. For cases of positive/negative discrepancy the
majority decision was adopted.
Molecular assays
A qPCR targeting the P. falciparum S-type 18S rRNA
genes was performed on all DNA samples to determine
parasite prevalence [27]. As a reference, a nested PCR
(nPCR) targeting the merozoite surface protein 2 (msp2)
was performed on all DNA samples [28]. Gametocytes
were detected by amplifying transcripts of the gametocyte-
specific expressed marker pfs25 [14]. pfs25 transcripts were
reverse transcribed and the resulting pfs25 cDNA was
amplified by qPCR. The RNA-based quantitative reverse
transcriptase PCR (qRT-PCR) assay was performed on all
extracted RNA samples after complete gDNA removal had
been confirmed by a qPCR assay targeting 18S rRNA genes
of all Plasmodium species [14]. To quantify P. falciparum
parasites and gametocytes, copy numbers of the respective
template per μL blood were calculated using standard
curves obtained from assay-specific plasmids routinely
included on each 96-well qPCR plate.
Data analysis
All data was entered and analysed by STATA® version 13,
Texas, USA. To compare the performance of different
diagnostic tests, concordance of results was recorded.
Parasite density/μL blood and marker-specific template
copy number/μL blood were converted to log10.
Results
This community survey included 330 individuals, the
mean age was 18 years with an age range of 1–81 years.
Of these, 21% were children <5 years, 44% were between
5–19 years. Individuals between 20–59 years and
adults >60 years accounted for 30% and 4.5% of re-
cruited individuals, respectively. A complete dataset in-
cluding all four diagnostic methods was obtained for 226
participants and used to compare test performance.Plasmodium falciparum prevalence and density
Prevalence of P. falciparum blood stages in the K-U
districts was 38% (86/226; 95% CI 31.9–44.4%) by Pf18S
rRNA qPCR. A lower parasite prevalence of 26.6% (60/
226; 95% CI 19–31.2%) was observed when msp2 nPCR
was performed. Of msp2 positive samples, 83.3% (50/60)
were confirmed by Pf18S rRNA qPCR. Only 58% (50/86)
of Pf18S rRNA qPCR-positive samples were positive by
msp2 nPCR (Table 1). Thus, sensitivity of qPCR was su-
perior to that of standard nPCR (Figure 1).
Plasmodium falciparum prevalence was 15.9% [(36/226;
95% CI 11.1–20.7%) by RDT and 5.8% (13/226; 95% CI
2.69- 8.81%) by LM. RDT was positive for 8/13 (61.5%)
and qPCR for 11/13 (84.6%) LM-positive samples.
Only 2/13 (15.4%) LM-positive samples were unidentified
by both RDT and qPCR, suggesting that these two LM
results were false positives (Table 2). Of 36 RDT-positive
samples, 26 (72.2%) were also positive by qPCR, whereas
the remaining 27.7% of RDT-positive samples were nega-
tive by qPCR and LM.
LM recorded a mean of 13,483 parasites/μL blood
(range 80 to 64,640). Pf18S rRNA qPCR detected a mean
of 6,524 18S rRNA gene copies/μL blood (range 0.9 to
155,293). 18S rRNA copy numbers were not converted
into parasite counts because trend-line experiments using
ring stage parasites were not performed for filter paper
blood spots with similar storage conditions. Moreover, ori-
ginal blood spots slightly varied in size and thus whole
blood content also varied. A non-linear correlation was
observed between log10 parasite density by LM and log10
18S rRNA gene copy numbers/μL blood for all microscopy
positive samples (Figure 2).
Gametocyte prevalence
Gametocyte prevalence was determined by LM and qRT-
PCR in 226 samples. Gametocyte carriage in the study
population was 10.6% (24/226; 95% CI 6.6–14.7%) by qRT-
PCR and 1.2% (3/226; 95% CI0.2–2.8%) by LM. Two of the
three gametocyte carriers identified by LM were confirmed
by molecular gametocyte detection. A large proportion of
gametocytaemia (87.5%; 21/24) was submicroscopic.
The proportion of molecularly-identified gametocyte
carriers among P. falciparum positive individuals is listed
Figure 1 Plasmodium falciparum prevalence rates by LM, RDT, msp2 nested PCR and 18S rRNA qPCR performed in N = 226 samples from
the Kilombero-Ulanga districts in Tanzania.
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(LM, RDT, msp2 nPCR and 18S rRNA qPCR). In total,
3/13(23%) LM-positive and 9/36 (25%) RDT-positive P.
falciparum infections harboured gametocytes detected
by pfs25 qRT-PCR. Among individuals deemed positive by
msp2 12/60 (20%) carried gametocytes. This proportion
was slightly higher than in individuals deemed positive
by the more sensitive 18S rRNA qPCR, with only 16.2%
(14/86) of infections harbouring gametocytes.
Discussion
Accurate estimation of malaria burden after implemen-
tation of effective malaria control programmes is of par-
ticular importance for evaluating and planning further
intervention strategies. Accuracy of the diagnostic tests
applied and knowledge of their limitations are essen-
tial. Therefore, we evaluated the performance of LM
and RDT, the routinely used methods for estimating P.
falciparum prevalence in the community, and compared
it with that of qPCR for determining parasite positivity.
Our results highlight the poor sensitivity of LM and the
high prevalence of submicroscopic infections. MalariaTable 2 Concordance among three different diagnostic
methods for detecting P. falciparum positivity
Patterns of test positivity by three diagnostic methods
18S rRNA qPCR
(Npos = 86)
RDT
(Npos = 36)
LM
(Npos = 13)
total positive samples
N = 98
+ - - 57
+ + - 18
- + - 10
+ + + 8
+ - + 3
- - + 2prevalence in the K-U districts is vastly underestimated,
if detection is based on LM only.
In many parts of Tanzania, LM is still widely used as
the standard parasite confirmation method because sup-
ply of RDTs is unreliable owing to stock-outs. With the
increasing success of interventions and as a consequence
of reduced clinical malaria, it becomes increasingly im-
portant to determine prevalence rates in the community
to estimate the remaining malaria burden and to monitor
the effect of sustained control measures. In this context,
the sensitivity of the diagnostic method, which greatly in-
fluences prevalence determination, becomes increasingly
important.
We observed a sevenfold difference between parasite
prevalence estimated by qPCR and that estimated by
LM. Other studies in Thailand, Myanmar [29,30] and
Malawi [31], as well as a systematic review [32] have also
reported more than two- to fivefold difference in asexual
stage parasite prevalence estimates between classical LM
and molecular detection. Several limitations of LM have
been documented [33], such as its dependency on the
expertise of the reader, the method of slide preparation,
staining and reading, and last but not least, its LOD of
about 50 parasites/μL blood. The LOD ranges from
20–100 parasites/μL blood between expert and field
microscopists. Thus, the high prevalence of submicro-
scopic infections in the K-U districts is not surprising, and
even slightly higher than in studies done elsewhere. Such
an abundance of submicroscopic infections is expected
in areas where malaria transmission has recently been
reduced successfully because parasite densities are con-
trolled by acquired immunity of previously exposed indi-
viduals [34].
Our study revealed that two of the 13 LM-positive
samples were negative by RDT and by both molecular
Figure 2 Comparison of log10 Plasmodium falciparum 18S rRNA gene copy numbers/μL blood by qPCR and log10 parasite counts/μL
blood by LM. *Two LM-positive samples were negative by RDT and molecular assays and likely represent false positive microscopy results.
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positives that may have resulted from erroneous thick
smear reads, as has been documented in other studies
[35]. Massive over-diagnosis of more than twenty-fivefold
difference in the prevalence rates (i.e. 53% versus 2%
prevalence) has been reported in a comparative study of
routine and expert LM in Tanzania [6].
The molecular methods (nPCR and qPCR) applied in
this study were slightly discordant in parasite detection.
This difference can be explained by a lower sensitivity of
msp2 nPCR compared to the 18S rRNA qPCR, which is
likely due to its greater amplicon size and thus less effi-
cient amplification. Moreover, compromised integrity of
parasite DNA could also lead to more efficient amplifica-
tion of the shorter 18S rRNA amplicon. However, some
samples which were positive using the marker msp2 were
negative by qPCR. In samples with very low parasite dens-
ities, a chance effect in the template distribution to oneTable 3 Proportion of P. falciparum gametocyte carriers amon
assays (18S rRNA qPCR and msp2 nested PCR)
Malaria diagnosis Gametocyte positive among Pf. positive samp
(% Gametocyte carriage among Pf. positives
LM 3/13 (23%)
RDT 9/36 (25%)
msp2 nPCR 12/60 (20%)
18S rRNA qPCR 14/86 (16%)reaction but not to the other could account for such dis-
crepant results. Alternatively, PCR inhibitors could poten-
tially be present in a sample, which may affect the qPCR
assay more than the nested PCR assay.
Our PCR data help to understand the difference be-
tween LM and RDT results in this study. The discrepan-
cies are likely due to the low sensitivity of LM as well as
to the residual HRP antigen that remains after a cleared
infection [36,37]. The LOD of RDTs is roughly compar-
able to LM in the field, although the last generation of
RDTs showed a higher sensitivity than previous ones
[38]. Moreover, RDTs performed better than LM in com-
munity surveys [12,39]. To estimate the proportion of
parasite infections undetected by LM and RDT, qPCR
with a substantially higher sensitivity of up to 0.34 para-
sites/μL blood was applied. The use of qPCR in our study
increased malaria prevalence twofold, which is similar to
differences between PCR- and RDT-detected prevalenceg individuals deemed positive by RDT, LM, or molecular
les
)
Gametocyte positive by molecular
Pfs25-qRT-PCR
Non gametocyte
carriers
3 10
9 27
12 48
14 72
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tive samples were negative by our most sensitive qPCR
assay. Variability in the interpretation of RDT results may
have contributed to the discordance between RDT and
PCR. A direct comparison between the results of qPCR
and RDT is generally problematic because these two tests
do not detect the same target molecule: while qPCR
detects DNA from circulating parasites, RDT detects
circulating antigens; hence a 100% concordant result is
not expected.
Another explanation for the discrepancies between
RDT, LM and PCR results could be that RDTs are actu-
ally capturing gametocytes in the absence of asexual
forms. pLDH is produced by live parasites including
gametocytes [41]. In confirmed samples containing only
P. falciparum gametocytes, RDT was positive in 72% of
samples with high gametocyte density (>500 gameto-
cytes/μL blood) compared to only 20.5% RDT positives
in samples with low gametocytaemia(>200 gametocytes/
μL blood) , suggesting that the presence of gametocytes
can compromise RDT results [42]. Similarly, among the
three samples in our study that were RDT positive but
qPCR negative, all harbored gametocytes by pfs25 qRT-
PCR. This could indicate the presence of gametocytes in
the absence of asexual forms. Negativity by qPCR in a
gametocyte-positive sample could be explained by the
presence of only three 18S rRNA gene copies per para-
site genome, whereas the numbers of pfs25 transcripts
are much higher [14]. Other molecular markers, specific
for asexual parasite stages, would be needed to prove the
absence of any asexual parasite.
In our study, the prevalence of gametocytes by pfs25
qRT-PCR was ten times higher than that by LM, indicat-
ing a high proportion of submicroscopic gametocytaemia
in the community. Based on the low gametocyte preva-
lence by LM in previous years and in the same popula-
tion [43], much higher gametocyte prevalence had been
anticipated, but was not confirmed until now. An even
greater difference in gametocyte detection between LM
and molecular analysis by Quantitative Nucleic Acid
Sequenced-based Amplification (QT-NASBA) has been
observed in a community survey in Tanzania (0.4% and
15% positivity, respectively) [44]. In malaria epidemiology,
submicroscopic gametocytaemia is important. It has been
shown that submicroscopic gametocyte carriage substan-
tially contributes to the human infective reservoir for
onward transmission to mosquitoes. These studies have
shown that even microscopy negative individuals can in-
fect mosquitoes [45,46]. Therefore, the observed 10.6%
gametocyte prevalence in our study population is likely to
sustain malaria transmission in the presence of an efficient
vector.
Over the seven-year course of malaria community sur-
veys in the K-U districts, molecular data were generatedonly during the 2011 survey. Therefore, the longitudinal
effect of interventions in the study area on P. falciparum
prevalence rates can only be analyzed by classical diagnos-
tic means. Previous LM data from the IHDSS recorded
declining malaria prevalence within the K-U districts,
from 25% in 2004 to 4.6% in 2009 [22,45]. The qPCR-
based prevalence rates obtained from the 2011 survey
now provide a more precise picture of the malaria preva-
lence in the K-U districts and put the very low prevalence
rate by LM into a new perspective. LM seems inadequate
as a diagnostic tool for surveillance of parasite infections
in Tanzania at a point when transmission intensity is shift-
ing from high to low. The question remains whether RDT
diagnosis should be considered a suitable alternative. This
test has the advantage of allowing on-site treatment for
symptomatic or asymptomatic individuals with positive
RDT results. It also allows comparison of data from dif-
ferent areas and countries that still use conventional tech-
niques. The future might be to use both, RDT for all
individuals and PCR in a subsample, to better gauge the
magnitude of underestimation of the parasite prevalence.
Molecular techniques should be used especially in areas
of very low endemicity, where elimination is the prime
objective.Conclusions
Light microscopy showed the poorest performance for
detecting both P. falciparum asexual parasites and game-
tocytes. This implies the presence of a large proportion of
submicroscopic parasitaemia and gametocytaemia in the
K-U districts, a phenomenon that is common in areas of
recently declining transmission. RDT performed better
than LM, as it detected almost half of the P. falciparum
carriers identified by molecular tools. However, in light of
the PCR results, the gain in sensitivity of RDT over LM
was still modest. However, the use of RDT adds to our
understanding of the real transmission level, in the sense
that it can also detect recently cleared infections (treated
or not) that are no more detectable by LM or PCR. Thus,
using both tools, PCR and RDT, which together are able
to detect actual parasitaemia plus recent infections, may
provide the most precise information by which to assess
the impact of interventions and to decide on the best con-
trol strategies. To reliably estimate the malaria reservoir in
areas of high submicroscopic parasitaemia, molecular
tools are clearly justified.Competing interests
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